B. Wirz

477 total citations
12 papers, 404 citations indexed

About

B. Wirz is a scholar working on Molecular Biology, Oncology and Organic Chemistry. According to data from OpenAlex, B. Wirz has authored 12 papers receiving a total of 404 indexed citations (citations by other indexed papers that have themselves been cited), including 6 papers in Molecular Biology, 5 papers in Oncology and 2 papers in Organic Chemistry. Recurrent topics in B. Wirz's work include Chemical Synthesis and Analysis (4 papers), Peptidase Inhibition and Analysis (3 papers) and Chemical Reactions and Isotopes (2 papers). B. Wirz is often cited by papers focused on Chemical Synthesis and Analysis (4 papers), Peptidase Inhibition and Analysis (3 papers) and Chemical Reactions and Isotopes (2 papers). B. Wirz collaborates with scholars based in Switzerland, India and United States. B. Wirz's co-authors include Alain Schweitzer, Dieter Seebàch, Beat Müeller, Mirjam Christ‐Crain, Philipp Schüetz, W. Zimmerli, Ulrike Glaenzel, Gerhard Groß, Felix Waldmeier and Jessica Valencia and has published in prestigious journals such as Clinical Chemistry, European Respiratory Journal and Drug Metabolism and Disposition.

In The Last Decade

B. Wirz

12 papers receiving 392 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
B. Wirz Switzerland 7 170 79 78 70 66 12 404
В. И. Шмурак Russia 9 178 1.0× 80 1.0× 36 0.5× 19 0.3× 46 0.7× 16 429
P. Farina Italy 11 202 1.2× 165 2.1× 53 0.7× 20 0.3× 81 1.2× 30 453
Jennifer M. Malinowski United States 6 117 0.7× 44 0.6× 30 0.4× 67 1.0× 37 0.6× 7 337
Donald K. Walker United Kingdom 7 113 0.7× 68 0.9× 26 0.3× 38 0.5× 14 0.2× 10 397
Sjoerd P. van Marle Switzerland 8 108 0.6× 76 1.0× 134 1.7× 69 1.0× 40 0.6× 8 533
Kanako Akamatsu Japan 13 130 0.8× 67 0.8× 219 2.8× 32 0.5× 67 1.0× 37 740
Yan Xia China 14 165 1.0× 31 0.4× 215 2.8× 19 0.3× 30 0.5× 36 646
Aziz Laurent United States 12 67 0.4× 58 0.7× 42 0.5× 115 1.6× 18 0.3× 15 416
Elizabeth A. Hausner United States 12 93 0.5× 43 0.5× 127 1.6× 13 0.2× 16 0.2× 18 422
Helen M. Dodds Australia 13 279 1.6× 174 2.2× 25 0.3× 63 0.9× 25 0.4× 26 479

Countries citing papers authored by B. Wirz

Since Specialization
Citations

This map shows the geographic impact of B. Wirz's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by B. Wirz with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites B. Wirz more than expected).

Fields of papers citing papers by B. Wirz

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by B. Wirz. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by B. Wirz. The network helps show where B. Wirz may publish in the future.

Co-authorship network of co-authors of B. Wirz

This figure shows the co-authorship network connecting the top 25 collaborators of B. Wirz. A scholar is included among the top collaborators of B. Wirz based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with B. Wirz. B. Wirz is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

12 of 12 papers shown
1.
Gschwind, Hans-Peter, Ulrike Glaenzel, Felix Waldmeier, et al.. (2012). Metabolism and disposition of the oral absorption enhancer 14C-radiolabeled 8-(N-2-hydroxy-5-chlorobenzoyl)-amino-caprylic acid (5-CNAC) in healthy postmenopausal women and supplementary investigations in vitro. European Journal of Pharmaceutical Sciences. 47(1). 44–55. 5 indexed citations
2.
Wirz, B., et al.. (2010). Inflammatory responses predict long-term mortality risk in community-acquired pneumonia. European Respiratory Journal. 37(6). 1439–1446. 73 indexed citations
3.
Waldmeier, Felix, Ulrike Glaenzel, B. Wirz, et al.. (2007). Absorption, Distribution, Metabolism, and Elimination of the Direct Renin Inhibitor Aliskiren in Healthy Volunteers. Drug Metabolism and Disposition. 35(8). 1418–1428. 104 indexed citations
4.
Weiss, H., B. Wirz, Alain Schweitzer, et al.. (2007). ADME Investigations of Unnatural Peptides: Distribution of a 14C‐Labeled β 3‐Octaarginine in Rats. Chemistry & Biodiversity. 4(7). 1413–1437. 28 indexed citations
5.
Wirz, B., Alain Schweitzer, Gerhard Groß, et al.. (2004). Pharmacokinetic Investigation of a 14C‐Labelled β3/α Tetrapeptide in Rats. Chemistry & Biodiversity. 1(11). 1812–1828. 38 indexed citations
6.
Wirz, B., Alain Schweitzer, Gian Camenisch, et al.. (2002). The outstanding metabolic stability of a 14C‐labeled β‐nonapeptide in rats – in vitro and in vivo pharmacokinetic studies. Biopharmaceutics & Drug Disposition. 23(6). 251–262. 78 indexed citations
7.
Buchdunger, Elisabeth, Helmut Mett, Uwe Trinks, et al.. (1995). 4,5-bis(4-fluoroanilino)phthalimide: A selective inhibitor of the epidermal growth factor receptor signal transduction pathway with potent in vivo antitumor activity.. PubMed. 1(8). 813–21. 24 indexed citations
8.
9.
Bendi, Anjaneyulu, et al.. (1985). Synthesis of 14C‐ and 3H‐labelled 4‐(4‐nitrophenyl)aminophenylisothiocyanate (GO 9333 / CGP 4540; amoscanate. Journal of Labelled Compounds and Radiopharmaceuticals. 22(4). 313–327. 5 indexed citations
10.
Wirz, B., et al.. (1983). Reaction of 14CO2 with grignard reagents to form either carboxylic acids or ketones. A novel convenient route to [2‐14C] glycerol and [1‐14C] Glycolic acid. Journal of Labelled Compounds and Radiopharmaceuticals. 20(5). 635–653. 4 indexed citations
11.
Faigle, J. W., et al.. (1983). Synthesis of carbon‐14‐ and tritium‐labelled 4‐amino‐3‐ (4‐chlorophenyl) ‐butyric acid (baclofen). Journal of Labelled Compounds and Radiopharmaceuticals. 20(2). 213–231. 5 indexed citations
12.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by В. И. Шмурак Breakdown of academic impact, for papers by P. Farina Breakdown of academic impact, for papers by Jennifer M. Malinowski Breakdown of academic impact, for papers by Donald K. Walker Breakdown of academic impact, for papers by Sjoerd P. van Marle Breakdown of academic impact, for papers by Kanako Akamatsu Breakdown of academic impact, for papers by Yan Xia Breakdown of academic impact, for papers by Aziz Laurent Breakdown of academic impact, for papers by Elizabeth A. Hausner Breakdown of academic impact, for papers by Helen M. Dodds
Rankless by CCL
2026